论文部分内容阅读
骨髓移植(BMT)患者由于接受多源性血制品的输注,染上乙肝病毒(HBV)的机会很多,常表现为病情凶险,同时亦是促使肝脏静脉闭塞性疾病发生及其GVHD累及肝脏的重要因素,因此如何提高BMT患者机体抗-HBV的能力至关重要。作者着重评价了自体BMT患者对HBV疫苗接种的抗体应答情况。 48例血清HBV阴性BMT患者,男27例,女21例,年龄4～57岁(平均33岁)。其中霍奇金病(HD)18
Bone marrow transplant (BMT) patients with multiple sources of blood products due to infusion of hepatitis B virus (HBV) have a lot of opportunities, often manifested as dangerous, but also to promote the occurrence of hepatic veno-occlusive disease and its involvement of GVHD liver Therefore, how to improve the ability of anti-HBV in the body of patients with BMT is very important. The authors highlighted the antibody response to HBV vaccination in patients with autologous BMT. 48 patients with HBV-negative serum BMT, 27 males and 21 females, aged 4 to 57 years (mean, 33 years). Which Hodgkin disease (HD) 18